APA aipamena

Pedersen, K. M., Çolak, Y., Hasselbalch, H. C., Bojesen, S. E., & Nordestgaard, B. G. (2020). Tocilizumab and soluble interleukin-6 receptor in JAK2V617F somatic mutation and myeloproliferative neoplasm. EClinicalMedicine.

Chicago Style aipamena

Pedersen, Kasper Mønsted, Yunus Çolak, Hans Carl Hasselbalch, Stig Egil Bojesen, and Børge Grønne Nordestgaard. "Tocilizumab and Soluble Interleukin-6 Receptor in JAK2V617F Somatic Mutation and Myeloproliferative Neoplasm." EClinicalMedicine 2020.

MLA aipamena

Pedersen, Kasper Mønsted, et al. "Tocilizumab and Soluble Interleukin-6 Receptor in JAK2V617F Somatic Mutation and Myeloproliferative Neoplasm." EClinicalMedicine 2020.